Royalty Pharma Plc (RPRX)
63.86
+0.11
(+0.17%)
USD |
NASDAQ |
Oct 23, 16:00
63.84
-0.02
(-0.03%)
Pre-Market: 20:00
Royalty Pharma Free Cash Flow : 612.50M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 612.50M |
| March 31, 2026 | 574.14M |
| December 31, 2025 | 897.24M |
| September 30, 2025 | 1.048B |
| June 30, 2025 | 827.02M |
| March 31, 2025 | 316.69M |
| December 31, 2024 | 268.93M |
| September 30, 2024 | -205.38M |
| June 30, 2024 | 400.94M |
| March 31, 2024 | 1.033B |
| December 31, 2023 | 916.16M |
| September 30, 2023 | 1.440B |
| June 30, 2023 | 535.27M |
| March 31, 2023 | 387.84M |
| Date | Value |
|---|---|
| December 31, 2022 | 381.12M |
| September 30, 2022 | 400.87M |
| June 30, 2022 | 312.08M |
| March 31, 2022 | 263.71M |
| December 31, 2021 | -173.44M |
| September 30, 2021 | -731.15M |
| June 30, 2021 | -158.50M |
| March 31, 2021 | -481.32M |
| December 31, 2020 | -132.53M |
| September 30, 2020 | 118.62M |
| June 30, 2020 | 808.48M |
| March 31, 2020 | 1.093B |
| December 31, 2019 | -54.05M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 16.06B |
| Johnson & Johnson | 19.98B |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 715.25M |
| Cash from Investing (Quarterly) | -216.51M |
| Cash from Financing (Quarterly) | -273.15M |
| Free Cash Flow Per Share (Quarterly) | 0.8336 |
| Free Cash Flow to Equity (Quarterly) | 458.78M |
| Free Cash Flow to Firm (Quarterly) | 557.84M |
| Free Cash Flow Yield | 1.83% |